Retour sur lavenir.net
   ARGENX SE 727.600 € (-4,09 %)     D'IETEREN GROUP 175.900 € (+2,03 %)     UMICORE 20.540 € (-0,19 %)     AZELIS GROUP 13.400 € (+0,75 %)     RETAIL ESTATES 62.400 € (-0,32 %)     AB INBEV 73.920 € (+1,37 %)     KINEPOLIS GROUP 49.850 € (-0,20 %)     SYENSQO 81.000 € (-2,41 %)     NYRSTAR 0.055 € (+3,77 %)     UCB 204.600 € (-0,68 %)     KBC ANCORA 96.500 € (+0,63 %)     MELEXIS 57.750 € (+1,76 %)     TESSENDERLO 18.300 € (-4,09 %)     INCLUSIO SA/NV 15.950 € (-0,93 %)     PROXIMUS 6.000 € (+2,13 %)     MONTEA 62.900 € (-0,47 %)     WDP 19.370 € (+0,21 %)     AGFA-GEVAERT 0.405 € (-1,82 %)     ONTEX GROUP 1.786 € (-1,43 %)     BPOST 1.130 € (+2,73 %)     ORANGE BELGIUM 22.200 € (+0,91 %)     TINC 10.540 € (-0,19 %)     IBA 16.380 € (+1,11 %)     ASCENCIO 52.500 € (-0,19 %)     KBC 121.100 € (+0,37 %)     TUBIZE-FIN 172.800 € (-0,75 %)     ECONOCOM GROUP 1.360 € (-2,86 %)     ACKERMANS V.HAAREN 263.000 € (+1,08 %)     NEXTENSA 44.400 € (+0,52 %)     ACCENTIS 0.027 € (+3,92 %)     VGP 62.600 € (-0,32 %)     GIMV 47.650 € (+0,11 %)     AGEAS 74.200 € (+0,88 %)     WERELDHAVE BELGIUM 50.600 € (+1,20 %)     SOLVAY 25.180 € (+0,24 %)     CIE BOIS SAUVAGE 276.000 € (-0,72 %)     BARCO 7.155 € (+2,80 %)     VASTNED 27.900 € (+0,72 %)     SIPEF 111.400 € (-1,07 %)     SOFINA 259.400 € (+0,31 %)     EKOPAK 2.400 € (-2,04 %)     ONWARD MEDICAL 2.345 € (-0,64 %)     CFE 11.400 € (-2,98 %)     BREDERODE 97.000 € (-0,41 %)     NYXOAH 1.000 € (-6,72 %)     CAMPINE 176.500 € (+0,86 %)     ENERGYVISION 17.940 € (-1,32 %)     COLRUYT 35.660 € (-0,17 %)     HOME INVEST BE. 17.860 € (-0,22 %)     FAGRON 23.500 € (+3,30 %)     VAN DE VELDE 29.300 € (-0,34 %)     ELIA GROUP 123.700 € (+1,98 %)     BEKAERT 39.800 € (+1,14 %)     FLUXYS BELGIUM D 20.700 € (0,00 %)     XIOR 23.750 € (+0,64 %)     DEME GROUP 167.400 € (+0,12 %)     CENERGY 21.800 € (+0,09 %)     EVS 19.480 € (+0,62 %)     AEDIFICA 62.950 € (-0,08 %)     BIOTALYS 1.740 € (+0,58 %)  
   AXA 42.970 € (+0,28 %)     EUROPLASMA 0.000 € (0,00 %)     LVMH 397.000 € (-0,33 %)     SAFRAN 317.000 € (0,00 %)     SAINT GOBAIN 66.540 € (0,00 %)     FORVIA 9.018 € (+2,50 %)     SANOFI 71.940 € (-0,30 %)     SBM OFFSHORE 35.320 € (+2,44 %)     DBT 0.061 € (0,00 %)     L'OREAL 407.400 € (+0,14 %)     CARREFOUR 16.610 € (-0,24 %)     PUBLICIS GROUPE SA 102.450 € (-1,25 %)     NN GROUP 76.460 € (+0,92 %)     TRACTIAL 2.580 € (+26,16 %)     CALIBRE 0.000 € (0,00 %)     RENAULT 27.590 € (+3,33 %)     STMICROELECTRONICS 41.170 € (-0,58 %)     SCOR SE 33.760 € (+1,08 %)     PLANISWARE 25.900 € (-1,89 %)     ENGIE 23.420 € (+0,90 %)     VALEO 13.950 € (+1,86 %)     DASSAULT AVIATION 303.800 € (+1,95 %)     SOCIETE GENERALE 64.470 € (-0,20 %)     UMG 16.265 € (+4,30 %)     SHELL PLC 46.880 € (+1,09 %)     BRUNEL INTERNAT 6.950 € (-0,86 %)     BANIJAY GROUP 8.000 € (-2,20 %)     MAUNA KEA TECH 0.114 € (+3,64 %)     SIGNIFY NV 14.590 € (+0,69 %)     KERING 216.950 € (+0,51 %)     VEOLIA ENVIRON. 32.400 € (+0,06 %)     EUROCASTLE INVEST. 14.000 € (+18,64 %)     CREDIT AGRICOLE 15.715 € (+0,45 %)     HEIJMANS KON 82.700 € (+3,25 %)     DSM FIRMENICH AG 107.050 € (-0,37 %)     AKZO NOBEL 59.020 € (-0,24 %)     CHRISTIAN DIOR 433.200 € (+0,46 %)     PHILIPS KON 23.160 € (+1,94 %)     ASML HOLDING 1 477.200 € (+0,89 %)     TECHNIP ENERGIES 30.980 € (+3,47 %)     RELX 34.680 € (+1,29 %)     ORANGE 14.565 € (+0,87 %)     UNILEVER 58.950 € (+1,38 %)     LEGRAND 134.000 € (+0,22 %)     UPERGY 1.645 € (+0,30 %)     LHYFE 1.644 € (-0,36 %)     CORBION 23.120 € (+0,09 %)     PROSUS 35.960 € (+0,03 %)     ARCELORMITTAL SA 56.800 € (+0,21 %)     BOUYGUES 41.510 € (+1,39 %)     KPN KON 4.088 € (+1,36 %)     FUGRO 7.315 € (+2,88 %)     ING GROEP N.V. 30.060 € (+1,49 %)     ENVIPCO HOLDING 3.430 € (0,00 %)     BE SEMICONDUCTOR 155.550 € (-4,80 %)     MEDINCELL 25.720 € (-2,28 %)     AALBERTS NV 41.420 € (+1,07 %)     HAFFNER ENERGY 0.700 € (-4,63 %)     2CRSI 26.240 € (-1,94 %)     DBV TECHNOLOGIES 1.568 € (-3,39 %)  
News Réglementées
16/10/2026 19:05

Paris Court Ruling on Discontinued Feature Will Have Minimal Impact on Angelalign Customers

EQS-News: Angelalign Technology Inc. / Key word(s): Legal Matter/Patent
Paris Court Ruling on Discontinued Feature Will Have Minimal Impact on Angelalign Customers

16.10.2026 / 19:05 CET/CEST
The issuer is solely responsible for the content of this announcement.


Angelalign Has Already Replaced Torque Ridges with Upgraded "Pressure Points" in Europe

SAN CLEMENTE, Calif., Oct. 16, 2026 /PRNewswire/ -- Angelalign Technology Inc. (6699.HK) ("Angel") http://www.angelaligner.com, a company driven by innovation in orthodontic clear aligner technology, said today that a ruling by the Paris Local Division of the Unified Patent Court concerning its Torque Ridges feature does not affect the availability of its offering in Europe, which already incorporates the next generation of torque-control technology. 

Angelalign Has Already Replaced Torque Ridges with Upgraded “Pressure Points” in Europe

Angel already has discontinued Torque Ridges in Europe and has replaced it with an upgraded feature called Pressure Points. Pressure Points, which launched in the European market in September, was designed to improve torque control and reflects Angel's continued commitment to innovation focused on solving orthodontists' clinical challenges. Angel customers in Spain, the UK and outside of Europe, including the Americas and Asia, are not affected by this ruling. Angel is constantly developing new solutions to continue to serve its customers well.

The court today ruled that the Torque Ridges feature infringes a patent held by Align Technology Inc. (ALGN) for repositioning a patient's teeth according to an orthodontic treatment plan. Angel respectfully disagrees with the decision and is reviewing it closely while it evaluates its options. Angel will comply with the court's ruling, including the return of any products. Because Torque Ridges is no longer offered in Europe, orthodontists using Angel products and services can continue treating their patients with access to Pressure Points and Angel's ongoing clinical and technical support.

"Our priority is to ensure that orthodontists can continue delivering excellent care to their patients," said Xavier Cherbavaz, General Manager and Vice President, Europe, Africa, and the Middle East, Angelalign Technology Inc. "Torque Ridges has already been retired in Europe and replaced with Pressure Points, an approach intended to support controlled force application and tooth contact. We remain focused on giving orthodontists innovative clinical solutions and a dependable customer experience."

"Angel takes intellectual property rights seriously and is careful not to infringe on valid patents," added Richard Hirschland, Angel's Chief Commercial Officer and SVP. "We are reviewing the court's reasoning carefully and will consider all available options. Angel will continue to innovate and improve its products to benefit its providers and their patients despite litigation by a competitor. Continuous innovation means anticipating challenges and preparing solutions to protect the customer experience. Our transition to Pressure Points reflects that commitment. We are determined to continue developing innovative solutions so that orthodontists can rely on Angel over the long term."

To learn more, visit angelaligner.com/eu and www.angelaligner.com.

About Angelalign Technology Inc.

Founded in 2003 and publicly listed since 2021, Angelalign Technology Inc. provides clear aligner solutions to clinically focused professionals and patients in over 60 countries. Having surpassed two million cumulative cases and with about a US$2 billion market capitalization, the company focuses on clinical innovation and professional support to help experts achieve extraordinary outcomes. Its established global operations and continued investment in innovation support its long-term commitment to orthodontists and their patients. Learn more at angelaligner.com.

Media Contact:

Sue Kolb
Angelalign Technology Inc.
sue.kolb@angelaligner.com

Angelalign Technology Inc., is a global provider of clear aligner technology with evidence based clinical expertise.  With over 20 years of experience and a commitment to research and digital innovation, Angelalign Technology Inc. has treated 1 million smiles, and is now expanding its expertise and global footprint.

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/paris-court-ruling-on-discontinued-feature-will-have-minimal-impact-on-angelalign-customers-302911488.html

rt.gif?NewsItemId=EN74308&Transmission_Id=202610161259PR_NEWS_EURO_ND__EN74308&DateId=20261016


16.10.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


2417514  16.10.2026 CET/CEST

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière